LITS

Healthcare Biotechnology

Lite Strategy, Inc.

$1.40

-0.01 -0.98% today

Price History

Not enough data

Key Stats

Market Cap

42.57M

Avg Volume

429,893

EPS

-$2.06

52W High

$2.97

52W Low

$0.69

Div. Yield

0.0%

Valuation

P/B Ratio

0.87

EV/EBITDA

-3.15

PEG Ratio

2.22

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(243.0%)

Return on Assets

(24.7%)

Liquidity & Leverage

Current Ratio

5.75

Quick Ratio

5.34

Total Cash

5.71M

Total Debt

About

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.